Lisbeth B.
- Country
- Denmark
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 93 partner sites.
Specializations
Oncology Focus
The investigator specializes in the treatment of Small Cell Lung Cancer (SCLC), with particular emphasis on advanced therapeutic approaches for patients who have undergone prior treatments.
- Relapsed SCLC Management
- Treatment-resistant Lung Cancer
- Post-platinum Therapy Options
Their research encompasses innovative therapeutic strategies for patients who have experienced disease progression after initial platinum-based treatments.
Therapeutic Innovation
The investigator focuses on evaluating novel therapeutic agents including lurbinectedin and its potential applications in lung cancer treatment protocols.
- Single-Agent Therapies
- Combination Treatment Approaches
- Comparative Treatment Efficacy
Their work includes assessment of both monotherapy and combination treatment strategies in advanced lung cancer scenarios.
Clinical Outcomes
The investigator's research concentrates on measuring and improving overall survival outcomes in patients with progressive lung cancer.
- Survival Rate Analysis
- Treatment Response Assessment
- Alternative Therapy Evaluation
Their expertise extends to comparative analysis of different treatment modalities in advanced lung cancer care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.